Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans?

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 69, Issue 19, 2006, Pages 1797-1804

  Yang, Chun Yuh ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER; TAP WATER; WELL WATER;

ARSENIC POISONING; ARTICLE; BLACKFOOT DISEASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; WATER CONTAMINATION; WATER SUPPLY; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; PERIPHERAL VASCULAR DISEASE; WATER POLLUTION;

ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; TAIWAN; WATER POLLUTION, CHEMICAL; WATER SUPPLY;

EID: 33747194411     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390600630237     Document Type: Article

References (42)

1. Bernstam, L., and Nriagu, J. 2000. Molecular aspects of arsenic stress. J. Toxicol. Environ. Health B 3:293-322.
2. Chang, C. C., Ho, S. C., Tsai, S. S., and Yang, C. Y. 2004. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J. Toxicol. Environ. Health A 67:1353-1361.
3. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res. 45:5895-5899.
4. Chen, C. J., Kuo, T. L., and Wu, M. M. 1988a. Arsenic and cancers. Lancet 1:414-415.
5. Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., and Wu, H. Y. 1988b. Atherogenicity and carcinogenicity of high-arsenic artesian well water: Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8:452-460.
6. Chen, C. J., Chiou, H. Y., Chiang, M. H., Lin, L. J., and Tai, T. Y. 1996. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 16:504-510.
7. Chen, G. S., Asai, T., Suzuki, Y., Nishioka, K., and Nishiyama, A. 1990. A possible pathogenesis for blackfoot disease: Effects of trivalent arsenic on cultured human umbilical vein endothelial cells. J. Dermatol. 17:599-608.
8. Chen, K. P., and Wu, H. Y. 1962. Epidemiologic studies on blackfoot disease in Taiwan. 2. A study of source of drinking water in relation to the disease. J. Formosan Med. Assoc. 61:611-618.
9. Chen, K. P., Wu, H. Y., and Wu, T. C. 1962. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Mem. Coll. Med. Natl. Taiwan Univ. 8:115-129.
10. Chen, W. Y., and Chen, K. P. 1975. Study on arsenic artesian well water and blackfoot disease progress. Taichung: Taiwan Provincial Institute of Environmental Sanitation.
11. Chiu, H. F., and Yang, C. Y. 2005. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan. J. Toxicol. Environ. Health A 68:319-327.
12. Chiu, H. F., Ho, S. C., Wang, L. Y., Wu, T. N., and Yang, C. Y. 2004a. Does arsenic exposure increase the risk for liver cancer. J. Toxicol. Environ. Health A 67:1491-1500.
13. Chiu, H. F., Ho, S. C., and Yang, C. Y. 2004b. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in southwestern Taiwan. Lung Cancer 46:265-270.
14. Engel, R. R., and Smith, A. H. 1994. Arsenic in drinking water and mortality from vascular disease: An ecologic analysis in 30 counties in the United States. Arch. Environ. Health 49:418-427.
15. Golub, M. S., Macintosh, M. S., and Baumrind, N. 1998. Developmental and reproductive toxicity of inorganic arsenic: Animal studies and human concerns. J. Toxicol. Environ. Health B 1:199-241.
16. Hansen, E. S. 1990. Shared risk factors for cancer and atherosclerosis: A review of the epidemiologic evidence. Mutat. Res. 239:162-179.
17. Hill, A. B. 1965. The environment and disease: Association or causation? Proc. R. Soc. Med. 58:295-300.
18. Hsueh, Y. M., Huang, Y. L., Huang, C. C., Wu, W. L., Chen, H. M., Yang, M. H., Lue, L. C., and Chen, C. J. 1998. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health A 54:431-444.
19. Levin, B., and Kline, J. 1985. The CuSum test of homogeneity with an application in spontaneous abortion epidemiology. Stat. Med. 4:469-488.
20. Lilienfeld, D. E. 1988. Arsenic, geographical isolates, environmental epidemiology and atherosclerosis. Atherosclerosis 8:449-451.
21. Lin, T. H., Huang, Y. L., and Wang, M. Y. 1998. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. J. Toxicol. Environ. Health 53:85-93.
22. Lloyd, O. L., Smith, G., Lloyd, M. M., and Gailey, F. 1985. Raised mortality from lung cancer and high sex ratios of births associated with industrial pollution. Br. J. Ind. Med. 42:475-480.
23. Lu, F. J. 1990. Blackfoot disease: Arsenic or humic acid? Lancet 336:115-116.
24. Lu, F. J., Tsai, M. H., and Ling, K. H. 1978. Studies on fluorescent compounds in drinking water of areas endemic for blackfoot disease. 3. Isolation and identification of fluorescent compounds. J. Formosan Med. Assoc. 77:68-76.
25. Morales, K. H., Ryan, L., Kuo, T. L., Wu, M. M., and Chen, C. J. 2000. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 108:655-661.
26. Morgenstern, H. 1982. Uses of ecologic analysis in epidemiological research. Am. J. Public Health 72:1336-1344.
27. Page, E. S. 1954. Continuous inspection schemes. Biometrika 41:100-115.
28. Rossi, G., Lampugnani, L., and Marchi, M. 1999. An approximate CuSum procedure for surveillance of health events. Stat. Med. 18:2111-2122.
29. Stroup, D. F., Wharton, M., Afadar, K., and Dean, A. G. 1993. Evaluation of a method for detecting aberrations in public health surveillance data. Am. J. Epidemiol. 137:373-380.
30. Thacker, S. B., and Berkelman, R. L. 1988. Public health surveillance in the United States. Epidemiol. Rev. 10:164-190.
31. Thacker, S. B., Berkelman, R. L., and Stroup, D. F. 1989. The science of public health surveillance. J. Public Health Policy 10:187-203.
32. Tsai, S. M., Wang, T. N., and Ko, Y. C. 1998. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement. J. Toxicol. Environ. Health A 55:389-404.
33. Tsai, S. M., Wang, T. N., and Ko, Y. C. 1999. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 54:186-193.
34. Tseng, W. P. 1989. Blackfoot disease in Taiwan: A 30-year follow-up study. Angiology 40:547-558.
35. Tseng, C. H., Chong, C. K., Chen, C. J., and Tai, T. Y. 1996. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120:125-133.
36. U.S. Environmental Protection Agency. 2001. National primary drinking water regulations; arsenic and clarification to compliance and new source contaminants monitoring; Final rule. Fed. Reg. 66:6976-7066.
37. Wang, C. H., Jeng, J. S., Yip, P. K., Chen, C. L., Hsu, L. I., Hsueh, Y. M., Chiou, H. Y., Wu, M. M., and Chen, C. J. 2002. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804-1809.
38. Wang, S. L., Chiou, J. M., Chen, C. J., Tseng, C. H., Chou, W. L., Wang, C. C., Wu, T. N., and Chang, L. W. 2003. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ. Health Perspect. 111:155-159.
39. Woodward, R. H., and Goldsmith, P. L. 1981. Cumulative Sum techniques, 2nd ed. Edinburgh: Oliver & Boyd.
40. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130:1123-1132.
41. Yang, C. Y., Cheng, B. H., Hsu, T. Y., Tsai, S. S., Hung, C. F., and Wu, T. N. 2000. Female lung cancer mortality and sex ratios at birth near a petroleum refinery plant. Environ. Res. 83:33-40.
42. Yang, C. Y., Chiu, H. F., Chang, C. C., Ho, S. C., and Wu, T. N. 2005. Bladder cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in southwestern Taiwan. Environ. Res. 98:127-132.